Class II · Moderate risk Ongoing
Desmopressin Nasal Spray
Reason Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Stimate
Class I — High risk. Reasonable probability of serious harm or death.
Why it was recalled
Superpotent Drug
What was recalled
STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL Behring LLC, King of Prussia, PA 19406-0901; By: Ferring GmbH, Kiel, Germany, NDC 0053-6871-00
- Recalling firm
- Ferring Pharmaceuticals Inc
- NDC code
- 0053-6871-00
- Origin
- NJ, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1506-2020
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Desmopressin recalls
See all
Class II · Moderate risk Terminated
Desmopressin Acetate Tablet
Reason Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Class II · Moderate risk Terminated
Desmopressin Acetate Tablets 0.2mg
Reason Subpotent Drug
Class II · Moderate risk Terminated
Desmopressin Acetate Tablets
Reason CGMP Deviations
Class II · Moderate risk Terminated
Desmopressin Acetate Injection USP
Reason Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.